🇺🇸 FDA
Pipeline program

Colchicine 0.5mg

KY2025-728

Phase 2 small_molecule active

Quick answer

Colchicine 0.5mg for Cerebral Amyloid Angiopathy is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Cerebral Amyloid Angiopathy
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials